サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701957

避妊薬市場：製品別、年齢層別、流通チャネル別、地域別、2025-2033年

Contraceptive Drugs Market Report by Product, Age Group, Distribution Channel, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 135 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
避妊薬市場：製品別、年齢層別、流通チャネル別、地域別、2025-2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

避妊薬市場の世界市場規模は2024年に166億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに255億米ドルに達し、2025～2033年の成長率（CAGR）は4.64％になると予測しています。

避妊薬とは、妊娠を防ぎ出生率をコントロールするために使用される避妊薬のことです。エストロゲンとプロゲスチンという2種類の女性ホルモンを用いて合成され、排卵を防ぐ。また、これらのホルモンは子宮頸管粘液を濃くしたり、子宮内膜を変化させたりして、受精や着床のために精子が子宮頸管に入るのを妨げます。避妊薬は、にきび、骨菲薄化、卵巣がん、卵管や子宮の感染症、月経前症候群（PMS）のリスクを下げるのを助けます。その結果、出産適齢期の女性の望まない妊娠を抑制するために、ヘルスケア専門医によって投与されます。現在、主に経口剤、注射剤、外用剤が販売されています。

避妊薬市場動向：

世界の避妊薬市場を牽引する主な要因の一つは、家族計画に関する消費者の意識の高まり、人口の増加、意図しない妊娠の増加です。これに伴い、最適な安全性、より良い臨床結果など複数の利点があることから、医療従事者が従来の方法よりも最新の避妊法に傾倒していることも成長を促す要因となっています。さらに、食品医薬品局（FDA）のような複数の規制機関による新薬の頻繁な承認が、市場の成長を支えています。さらに、膣内のpHレベルを維持することで精子が生存しにくい環境を作り出すゼラチンカプセルや非ホルモン性膣ゲルの登場が、市場の成長を促しています。これとは別に、継続的な研究開発（R&D）活動や、非政府組織（NGO）や保健機関が避妊技術や女性の健康、性的ウェルネスについて消費者を啓発するために行っている好意的な取り組みが、市場の成長を積極的に後押ししています。

本レポートで扱う主な質問

  • 2024年の世界の避妊薬市場の市場規模は？
  • 2025-2033年における世界の避妊薬市場の予想成長率は？
  • 世界の避妊薬市場を牽引する主要因は何か？
  • 世界の避妊薬市場に対するCOVID-19の影響は？
  • 世界の避妊薬市場の製品別内訳は？
  • 世界の避妊薬市場の年齢層別内訳は？
  • 世界の避妊薬市場の流通チャネル別内訳は？
  • 世界の避妊薬市場における主要地域は？
  • 世界の避妊薬市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の避妊薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 経口避妊薬
  • 注射避妊薬
  • 局所避妊薬

第7章 市場内訳：年齢層別

  • 15～24歳
  • 25～34歳
  • 35～44歳
  • 44歳超

第8章 市場内訳：流通チャネル別

  • 小売薬局
  • 病院薬局
  • クリニック
  • オンラインチャネル
  • 公共チャネル・NGO
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • Afaxys Inc.
    • Agile Therapeutics
    • Amneal Pharmaceuticals Inc.
    • Bayer AG
    • Johnson & Johnson
    • Mithra Pharmaceuticals SA
    • Novartis AG
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
図表

List of Figures

  • Figure 1: Global: Contraceptive Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Contraceptive Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Contraceptive Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Contraceptive Drugs Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Contraceptive Drugs Market: Breakup by Age Group (in %), 2024
  • Figure 6: Global: Contraceptive Drugs Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Contraceptive Drugs Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Contraceptive Drugs (Injectable Contraceptives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Contraceptive Drugs (Injectable Contraceptives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Contraceptive Drugs (Topical Contraceptives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Contraceptive Drugs (Topical Contraceptives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Contraceptive Drugs (15-24 years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Contraceptive Drugs (15-24 years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Contraceptive Drugs (25-34 years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Contraceptive Drugs (25-34 years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Contraceptive Drugs (35-44 years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Contraceptive Drugs (35-44 years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Contraceptive Drugs (Above 44 years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Contraceptive Drugs (Above 44 years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Contraceptive Drugs (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Contraceptive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Contraceptive Drugs (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Contraceptive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Contraceptive Drugs (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Contraceptive Drugs (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Contraceptive Drugs (Online Channel) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Contraceptive Drugs (Online Channel) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Contraceptive Drugs (Public Channel and NGOs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Contraceptive Drugs (Public Channel and NGOs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Contraceptive Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Contraceptive Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia-Pacific: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Contraceptive Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Contraceptive Drugs Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: Contraceptive Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: Contraceptive Drugs Industry: SWOT Analysis
  • Figure 84: Global: Contraceptive Drugs Industry: Value Chain Analysis
  • Figure 85: Global: Contraceptive Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Contraceptive Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Contraceptive Drugs Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Contraceptive Drugs Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 4: Global: Contraceptive Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Contraceptive Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Contraceptive Drugs Market: Competitive Structure
  • Table 7: Global: Contraceptive Drugs Market: Key Players
目次
Product Code: SR112025A6300

The global contraceptive drugs market size reached USD 16.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.64% during 2025-2033.

Contraceptive drugs refer to birth control medications that are used to prevent pregnancy and control the birth rate. They are synthetically formulated using two female hormones, namely estrogen and progestin, which prevent ovulation. These hormones also thicken cervical mucus or alter the womb lining to prohibit the entrance of sperm into the cervix for fertilization and implantation. Contraceptive drugs assist in lowering the risks of acne, bone thinning, ovarian cancer, infections in the fallopian tubes and uterus, and premenstrual syndrome (PMS). As a result, they are administered by healthcare practitioners to inhibit unwanted pregnancy amongst women of childbearing age. At present, they are mainly available in oral, injectable, and topical formulations.

Contraceptive Drugs Market Trends:

One of the key factors driving the global contraceptive drugs market is the rising consumer consciousness regarding family planning, the increasing population, and the rising instances of unintended pregnancies. In line with this, the shifting inclination of healthcare practitioners toward modern contraceptive methods over conventional procedures, owing to their multiple benefits, including optimal safety, and better clinical outcomes, are acting as another growth-inducing factor. Additionally, the frequent approvals of novel medications by several regulatory bodies, such as the food and drug administration (FDA), are supporting the market growth. Moreover, the advent of gelatin capsules and non-hormonal vaginal gels that create an inhospitable environment for sperm to sustain by maintaining vagina pH levels is impelling the market growth. Apart from this, continuous research and development (R&D) activities and the favorable initiatives undertaken by non-governmental organizations (NGOs) and health agencies to sensitize consumers about contraception techniques, women's health, and sexual wellness are positively augmenting the market growth.

Key Market Segmentation:

Breakup by Product:

  • Oral Contraceptive Pills
  • Injectable Contraceptives
  • Topical Contraceptives

Breakup by Age Group:

  • 15-24 years
  • 25-34 years
  • 35-44 years
  • Above 44 years

Breakup by Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Clinics
  • Online Channel
  • Public Channel and NGOs
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Afaxys Inc., Agile Therapeutics, Amneal Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Mithra Pharmaceuticals SA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Viatris Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global contraceptive drugs market in 2024?
  • 2.What is the expected growth rate of the global contraceptive drugs market during 2025-2033?
  • 3.What are the key factors driving the global contraceptive drugs market?
  • 4.What has been the impact of COVID-19 on the global contraceptive drugs market?
  • 5.What is the breakup of the global contraceptive drugs market based on the product?
  • 6.What is the breakup of the global contraceptive drugs market based on the age group?
  • 7.What is the breakup of the global contraceptive drugs market based on the distribution channel?
  • 8.What are the key regions in the global contraceptive drugs market?
  • 9.Who are the key players/companies in the global contraceptive drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Contraceptive Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oral Contraceptive Pills
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injectable Contraceptives
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Topical Contraceptives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 15-24 years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 25-34 years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 35-44 years
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Above 44 years
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Channel
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Public Channel and NGOs
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Afaxys Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Agile Therapeutics
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Amneal Pharmaceuticals Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bayer AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mithra Pharmaceuticals SA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teva Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Viatris Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials